The bioT3 platform

Videos - Interview with the Innovators
Dr. Boccia describes the components of the bioT3 platform and its clinical utility in identifying tumor type and actionable targets for therapy.
Related Items
Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer
Robyn Bilmes, Leslie Amendola
Videos published on September 28, 2022 in Interview with the Innovators
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Kate Sasser, Hisham Hamadeh
Videos published on July 8, 2022 in Interview with the Innovators
Genmab Is Ready to Enter the US Market to Help Improve the Lives of People with Cancer
Ron Graybill, Brad Bailey
Videos published on June 2, 2022 in Interview with the Innovators
Introducing Genmab-Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment
Anthony Mancini, Ron Graybill
Videos published on April 15, 2022 in Interview with the Innovators
Unclear Diagnoses in Patients with Metastatic Disease
Ralph V. Boccia, MD, FACP
Videos published on April 14, 2015 in Interview with the Innovators
Last modified: August 30, 2021
Copyright © Engage Healthcare Communications, LLC. All rights reserved.